- Home
- EVOK vs AQB Comparison
EVOK vs AQB Comparison
Compare EVOK & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- AQB
- Stock Information
- Founded
- EVOK 2007
- AQB 1991
- Country
- EVOK United States
- AQB United States
- Employees
- EVOK N/A
- AQB N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- AQB
- Sector
- EVOK Health Care
- AQB
- Exchange
- EVOK Nasdaq
- AQB Nasdaq
- Market Cap
- EVOK 7.6M
- AQB 6.4M
- IPO Year
- EVOK 2013
- AQB N/A
- Fundamental
- Price
- EVOK $5.15
- AQB $1.30
- Analyst Decision
- EVOK
- AQB
- Analyst Count
- EVOK 0
- AQB 0
- Target Price
- EVOK N/A
- AQB N/A
- AVG Volume (30 Days)
- EVOK 26.0K
- AQB 131.3K
- Earning Date
- EVOK 11-07-2025
- AQB 10-28-2025
- Dividend Yield
- EVOK N/A
- AQB N/A
- EPS Growth
- EVOK N/A
- AQB N/A
- EPS
- EVOK N/A
- AQB N/A
- Revenue
- EVOK $12,794,859.00
- AQB N/A
- Revenue This Year
- EVOK $57.38
- AQB N/A
- Revenue Next Year
- EVOK $59.57
- AQB N/A
- P/E Ratio
- EVOK N/A
- AQB N/A
- Revenue Growth
- EVOK 70.02
- AQB N/A
- 52 Week Low
- EVOK $1.94
- AQB $0.47
- 52 Week High
- EVOK $9.88
- AQB $2.95
- Technical
- Relative Strength Index (RSI)
- EVOK 57.04
- AQB 37.67
- Support Level
- EVOK $4.53
- AQB $1.39
- Resistance Level
- EVOK $5.19
- AQB $1.97
- Average True Range (ATR)
- EVOK 0.28
- AQB 0.13
- MACD
- EVOK 0.07
- AQB -0.07
- Stochastic Oscillator
- EVOK 91.26
- AQB 5.63
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.